Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
about
Role of neuroimaging in HIV-associated neurocognitive disordersNeural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individualsNeuroimaging of HIV-associated neurocognitive disorders (HAND)Novel Neuroimaging Methods to Understand How HIV Affects the BrainNeurocognitive effects of HIV, hepatitis C, and substance use historyPredictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.Glutamate metabolism and HIV-associated neurocognitive disorders.HIV-associated neurocognitive disorder.Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection.Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.Verbal memory declines more rapidly with age in HIV infected versus uninfected adultsEffects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behaviorHIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Relationship of plasma cytokines and clinical biomarkers to memory performance in HIVPlasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.Independent effects of HIV, aging, and HAART on brain volumetric measures.Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and ageA pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in HIV disease.Regional cortical thinning associated with detectable levels of HIV DNA.Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral TherapyAerobic fitness and the brain: increased N-acetyl-aspartate and choline concentrations in endurance-trained middle-aged adultsPatterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study.Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapyProgressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.Effects of HIV and childhood trauma on brain morphometry and neurocognitive function.Mapping white matter integrity in elderly people with HIVIncreases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionDisrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatmentQuantitative MRI Measures in SIV-Infected Macaque Brains.HIV clades B and C are associated with reduced brain volumetricsA biological perspective of CSF lipids as surrogate markers for cognitive status in HIVClinical contributors to cerebral white matter integrity in HIV-infected individualsAltered structural brain changes and neurocognitive performance in pediatric HIV.PTSD co-morbid with HIV: Separate but equal, or two parts of a whole?Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition.Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains.
P2860
Q26852705-7122739E-D059-4E86-B0E0-D41BCD099223Q30405829-85D5B169-E48A-4275-A91D-832763C327DCQ30854917-78AF7405-62D0-4FC5-9E2E-A0A8C703E3C0Q30938624-585CA72F-0352-4FF5-B0C2-DAE8DBD1A924Q33652957-CF3D2B2F-3717-4896-B9E0-9C42A5497AA0Q33699222-80F41774-E50A-4466-8CD7-F93471330E3FQ33903612-0AA8BC84-C280-4A3D-A873-9869FCC005DDQ33939729-B568FD61-2E05-4E95-B927-951BD0AA8B07Q34508049-69AF5505-6155-473C-94AB-66EE3790658EQ34778881-9C3FDCED-F707-44A4-A084-80A64301FC0AQ35023780-57872B22-09A9-4892-BCD6-7A3CD3D33E67Q35050070-57A77147-54C1-4BE7-8B06-698CEE96F6F1Q35123216-446D5827-3311-4AD8-A062-750CCDEAA2E0Q35276630-39CA5669-4B89-4DB5-89A1-C5F3B2BA3CF8Q35576425-5A562B89-2F37-4727-9767-0EFA53CB0970Q35582240-C120308E-D644-4C75-9485-A6A0DF7E2A8DQ35827867-8FE6BA71-E115-42AF-8D66-653107652D39Q36087139-77D7D2EB-729F-4CFB-9F9F-14086EC8608BQ36089644-07AF67A3-E8CD-4D02-87F9-109179F7B98DQ36142331-81DCFA76-D3EA-45E3-95B6-20C0C415268DQ36463660-62CCD5E1-DC46-4F1D-9336-0ACAF8B0A76EQ36511178-FC34AA6C-3CF0-4012-91DF-2882DED77C8DQ36597928-0C792951-CB23-438F-8516-AC6599F71E7BQ36619628-830F41AF-269B-4005-B10D-C748B2C5BC9EQ36892965-79B03719-9EA2-44B1-88E3-757631737D6BQ37086701-DE48B2E0-ADD0-4066-9B36-4649C6D52E61Q37123124-E19BABB7-392D-4B37-A2EC-8DEAF87C17EDQ37179026-3E2BDEDC-37CD-4C4C-A119-EC99246BA69CQ37181324-5D9E9EA2-C2ED-4A82-8BE7-9CC57818C1C2Q37217155-9AF70FD3-DEAF-4BA2-8207-ABC6E5A8A595Q37305895-C8F236D1-6EBB-4E42-A7CD-BD249FF18436Q37354426-A56F90A6-D6B7-4782-A165-986ABC3AA410Q37541514-3A93A96D-BADB-4528-89CE-8BC4EE18553BQ37561725-6CA9FD45-47BF-4E75-811C-3133A5979560Q37638105-4D4F5B2A-D860-471E-B9A6-EF2E4ADDF654Q38642340-3130F8AE-FA39-4BFC-94C3-A4327772C2A6Q38770217-7333497F-F4AF-43B3-94A4-F3B91EB6CC38Q39563761-E6C3539C-7AC9-40E4-B446-AA6517B38FD7Q40215147-F4A826FD-86A2-48C9-8164-AC39938684FAQ40261770-B51DBACA-EE70-41C7-92C5-A4B00C76034D
P2860
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@ast
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@en
type
label
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@ast
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@en
prefLabel
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@ast
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@en
P2093
P2860
P50
P356
P1476
Cerebral metabolite abnormalit ...... tical and subcortical volumes.
@en
P2093
Bradford Navia
David Tate
Deborah McMahon
Elyse Singer
Giovanni Schifitto
Jaroslaw Harezlak
Jeffery Alger
Jianhui Zhong
Mark Brown
P2860
P2888
P304
P356
10.1007/BF03210849
P577
2010-10-20T00:00:00Z